Core Viewpoint - The company,药捷安康-B (02617), has been selected to be included in various Hang Seng Index series, effective from September 8, 2025, indicating an increase in investor recognition [1] Group 1: Index Inclusion - The company will be included in the Hang Seng Composite Index [1] - The company will also be part of the Hang Seng Composite Industry Index - Healthcare [1] - Additional indices include the Hang Seng Composite Small Cap Index and the Hang Seng Healthcare Index [1] Group 2: Investor Recognition - Inclusion in the Hang Seng Composite Index and other indices reflects a rising recognition from investors [1] - The company is also set to be part of the Hang Seng Innovation Drug Index and the Hang Seng Hong Kong Stock Connect Innovation Drug Index [1] - The recognition is further emphasized by the inclusion in the Hang Seng Hong Kong Stock Connect Drug and Biotechnology (Investable) Index [1]

Core Viewpoint - The company Yunzhisheng (09678) has been selected to be included in various Hang Seng Index series, effective from September 8, 2025, which is expected to enhance its investment value and reputation in the capital market [1]. Group 1 - The company will be included in the following Hang Seng Index series: 1. Hang Seng Composite Index; 2. Hang Seng Composite Industry Index - Information Technology; 3. Hang Seng Composite Small Cap Index; 4. Hang Seng Composite Micro Cap Index; 5. Hang Seng Internet Technology Index; 6. Hang Seng Information Technology Index; 7. Hang Seng Information Technology (Investable) Index; 8. Hang Seng Hong Kong Stock Connect Information Technology Index; 9. Hang Seng Hong Kong Stock Connect Software and Semiconductor (Investable) Index; 10. Hang Seng Hong Kong Stock Connect Software and Semiconductor Index [1]. - The Hang Seng Index series is widely referenced and reflects the performance of the Hong Kong stock market [1]. - The board believes that inclusion in the Hang Seng Composite Index will help expand the shareholder base [1].

Core Viewpoint - The company, Baize Medical (02609), has been selected to be included in various Hang Seng Index series components effective from September 8, 2025, reflecting increased investor recognition of its operational performance and growth potential [1] Group 1: Index Inclusion - Baize Medical will be included in the Hang Seng Composite Index, Hang Seng Composite Industry Index - Healthcare, Hang Seng Composite Small Cap Index, Hang Seng Healthcare Index, and other related indices [1] - The Hang Seng Composite Index covers the top 95% of total market capitalization of companies listed on the Hong Kong Stock Exchange, serving as a comprehensive market benchmark [1] Group 2: Market Impact - Inclusion in the Hang Seng Composite Index will qualify the company's shares for trading through the Hong Kong Stock Connect programs, enhancing accessibility for mainland Chinese investors [1] - The board anticipates that this inclusion will increase the company's visibility in the capital markets, improve trading liquidity, and further enhance its investment value [1]

Core Viewpoint - The company, Baize Medical (02609), has been selected to be included in various Hang Seng Index series, effective from September 8, 2025, reflecting increased investor recognition of its operational performance and growth potential [1] Group 1: Inclusion in Hang Seng Index - Baize Medical will be included in the Hang Seng Composite Index, Hang Seng Composite Industry Index - Healthcare, Hang Seng Composite Small Cap Index, Hang Seng Healthcare Index, and other related indices [1] - The Hang Seng Composite Index covers the top 95% of total market capitalization of companies listed on the Hong Kong Stock Exchange, serving as a comprehensive market benchmark [1] Group 2: Impact on Market Presence - Inclusion in the Hang Seng Composite Index will qualify the company's shares for trading through the Hong Kong Stock Connect programs, enhancing accessibility for mainland Chinese investors [1] - The board anticipates that this inclusion will increase the company's visibility in the capital markets, improve trading liquidity, and further enhance its investment value [1]